ZW2485A1 - Cloning of dna for protozoal antigens - Google Patents

Cloning of dna for protozoal antigens

Info

Publication number
ZW2485A1
ZW2485A1 ZW24/85A ZW2485A ZW2485A1 ZW 2485 A1 ZW2485 A1 ZW 2485A1 ZW 24/85 A ZW24/85 A ZW 24/85A ZW 2485 A ZW2485 A ZW 2485A ZW 2485 A1 ZW2485 A1 ZW 2485A1
Authority
ZW
Zimbabwe
Prior art keywords
cloning
dna
protozoal antigens
protozoal
antigens
Prior art date
Application number
ZW24/85A
Other languages
English (en)
Inventor
Arthur Holder Anthony
Singh Sandhu Jasbir
Gerrit Odink Karel
James Lockyer Michael
Riveros-Moreno Valentina
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848404692A external-priority patent/GB8404692D0/en
Priority claimed from GB848424340A external-priority patent/GB8424340D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZW2485A1 publication Critical patent/ZW2485A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZW24/85A 1984-02-22 1985-02-21 Cloning of dna for protozoal antigens ZW2485A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848404692A GB8404692D0 (en) 1984-02-22 1984-02-22 Cloning of dna for protozoal antigens
GB848424340A GB8424340D0 (en) 1984-09-26 1984-09-26 Cloning of dna

Publications (1)

Publication Number Publication Date
ZW2485A1 true ZW2485A1 (en) 1986-09-24

Family

ID=26287348

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW24/85A ZW2485A1 (en) 1984-02-22 1985-02-21 Cloning of dna for protozoal antigens

Country Status (14)

Country Link
US (1) US5597708A (da)
EP (1) EP0154454B1 (da)
JP (2) JP2584733B2 (da)
AT (1) ATE64957T1 (da)
AU (1) AU592749B2 (da)
CA (1) CA1340103C (da)
DE (1) DE3583347D1 (da)
DK (1) DK79985A (da)
GB (1) GB2154592A (da)
HU (1) HU200794B (da)
IL (1) IL74409A (da)
NZ (1) NZ211191A (da)
PH (1) PH25993A (da)
ZW (1) ZW2485A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3584300D1 (de) * 1984-02-21 1991-11-14 Nat Res Dev Herstellung von malaria-impfstoffen.
IL76338A (en) * 1984-09-11 1994-08-26 Saramane Pty Ltd Plasmodium plasmodium immunogenic polypeptides, AND molecules encoding them, a method for preparing the polypeptides and preparations containing the polypeptide
IL78476A0 (en) * 1985-04-11 1986-08-31 Inst Medical W & E Hall Highly repetitive antigens of plasmodium falciparum
US4978621A (en) * 1985-09-03 1990-12-18 Scripps Clinic And Research Foundation Merozoite surface antigens
IL81026A0 (en) * 1985-12-24 1987-03-31 Inst Medical W & E Hall Peptides for immunizing against plasmodium falciparum,dna molecules coding for them and compositions containing said peptides
EP0252588A3 (en) * 1986-05-12 1989-07-12 Smithkline Beecham Corporation Process for the isolation and purification of p. falciparum cs protein expressed in recombinant e. coli, and its use as a vaccine
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
GB8706599D0 (en) * 1987-03-19 1987-04-23 Hoffmann La Roche Plasmodium falciparum merozoite antigen peptides
DE3737238A1 (de) * 1987-11-03 1989-05-18 Behringwerke Ag Rekombinantes histidinreiches protein (37 kd antigen) von plasmodium falciparum, seine herstellung und verwendung
AT388934B (de) * 1987-11-13 1989-09-25 Wellcome Found Rekombinationskonjugatprotein und neue vakzinen
DE3831351A1 (de) * 1987-12-30 1989-07-13 Behringwerke Ag Malaria-spezifische dna-sequenzen, ihre expressionsprodukte und deren verwendung
US6333406B1 (en) 1988-08-12 2001-12-25 Joseph W. Inselburg Gene encoding protein antigens of Plasmodium falciparum and uses therefor
US5756101A (en) * 1991-07-01 1998-05-26 Pasteur Merieux Serums Et Vaccins Malaria recombinant poxvirus
US6855316B1 (en) * 1994-02-14 2005-02-15 University Of Hawaii Baculovirus produced Plasmodium falciparum vaccine
FR2744724B1 (fr) * 1996-02-14 2002-08-02 Pasteur Institut Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
FR2744723A1 (fr) * 1996-02-14 1997-08-14 Pasteur Institut Proteine recombinante contenant un fragment c-terminal d'une proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
DE19640817A1 (de) * 1996-10-02 1998-05-14 Hermann Prof Dr Bujard Rekombinantes Herstellungsverfahren für ein vollständiges Malaria-Antigen gp190/MSP 1
UY27304A1 (es) 2001-05-24 2002-12-31 Avanir Pharmaceuticals Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación
US20040082048A1 (en) * 2002-10-15 2004-04-29 Viswanath Nittala Venkata Narasimha Genes and protein sequences useful as drug targets for therapeutic action against protozoa
TW200418829A (en) * 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AU2004268941A1 (en) * 2003-08-22 2005-03-10 Avanir Pharmaceuticals Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
US20060229314A1 (en) 2005-03-24 2006-10-12 Jagadish Sircar Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
GB0605689D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic compounds
US7931908B2 (en) * 2007-02-23 2011-04-26 Philadelphia Health Education Corporation Chimeric MSP-based malaria vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
IL65496A (en) * 1981-04-15 1985-10-31 Wellcome Found Protozoal antigen,its preparation and vaccine containing it
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
GB8404378D0 (en) * 1984-02-20 1984-03-28 Biogen Nv Dna sequence recombinant dna molecules

Also Published As

Publication number Publication date
DK79985A (da) 1985-08-23
GB8504429D0 (en) 1985-03-27
GB2154592A (en) 1985-09-11
EP0154454B1 (en) 1991-07-03
NZ211191A (en) 1988-01-08
IL74409A (en) 1994-08-26
AU3904685A (en) 1985-09-05
JP2584733B2 (ja) 1997-02-26
ATE64957T1 (de) 1991-07-15
DE3583347D1 (de) 1991-08-08
CA1340103C (en) 1998-10-27
DK79985D0 (da) 1985-02-21
AU592749B2 (en) 1990-01-25
JPH06189772A (ja) 1994-07-12
JPS6119490A (ja) 1986-01-28
HU200794B (en) 1990-08-28
JP2893626B2 (ja) 1999-05-24
HUT37460A (en) 1985-12-28
PH25993A (en) 1992-01-13
US5597708A (en) 1997-01-28
EP0154454A1 (en) 1985-09-11
IL74409A0 (en) 1985-05-31

Similar Documents

Publication Publication Date Title
IL74409A0 (en) Cloning of dna for protozoal antigens
DE3760912D1 (en) Retrovirus of the type hiv-2 capable of inducing aids, and the antigenic and nucleic acid components thereof
ZA853081B (en) Vaccine against rabies and process for preparation thereof
ZA851305B (en) Dna sequences,recombinant dna molecules and processes for producing late schizont-merozoite stage specific antigens of the human malarial parasite plasmodium falciparum
ZA886273B (en) Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids
PT84850A (en) Process for isolating and purifying p.falciparum cs protein vaccine expressed in recombinant e.coli
EP0273800A3 (en) Hirudine variants, their use and preparation
ZA884486B (en) Promoters for the expression of foreign dna in methylotrophic bacteria,the obtaining thereof and the use thereof
EP0363436A4 (en) CLONED GENES OF PROTEIN G VERSIONS AND PROTEIN G VERSIONS EXPRESSED THEREOF.
ES2087092T3 (es) Procedimiento para la expresion de poligalacturonidasa y pectinesterasa en aspergillus niger y aspergillus awamori.
FI884485A7 (fi) P. falciparumin sporotsoiitin pintaproteiinin muodostuminen hiivassa
IL81026A0 (en) Peptides for immunizing against plasmodium falciparum,dna molecules coding for them and compositions containing said peptides
IL85759A0 (en) The cloning of malaria-specific dna sequences,isolation of the gene for the 140 kd protein
ZA898479B (en) Injury-stimulated dna sequence from solanum tuberosum,and use thereof
NZ233255A (en) Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope
ZA902436B (en) Purification of c.pseudotuberculosis toxin,and cloning and expression of toxin gene
CA1266268C (en) CARDIOTONIC AROYLTHIAZOLONES
EP0322712A3 (en) Dna sequences specific for malaria, their expression products and applications thereof
ATE61818T1 (de) Dns-sequenzen, rekombinante dns und verfahren zur herstellung von plasmodium-falciparumantigenen.
Gines Cloning and expression of the Aspergillus Oryzae o-Amylase gene.
ATE84315T1 (de) Rekombinante dna zur reprimierbaren und induzierbaren expression von fremdgenen.
IE871212L (en) "process for isolating and purifying p. falciparum cs¹protein vaccine expressed in recombinant e. colt"
IT8619078A0 (it) Procedimento di trattamento speciale per prodotti in sughero.